c-Met abnormatities in patients with genitourinary (GU) malignancies and outcomes with c-MET inhibitors.
Denis Leonardo Fontes Jardim
No relevant relationships to disclose
Debora De Melo Gagliato
No relevant relationships to disclose
Gerald Steven Falchook
Research Funding - EMD Serono
Jennifer J. Wheler
No relevant relationships to disclose
Ralph Zinner
No relevant relationships to disclose
Filip Janku
No relevant relationships to disclose
Vivek Subbiah
No relevant relationships to disclose
Sarina Anne Piha-Paul
No relevant relationships to disclose
Siqing Fu
No relevant relationships to disclose
Nizar M. Tannir
No relevant relationships to disclose
Paul Gettys Corn
No relevant relationships to disclose
Chad Tang
No relevant relationships to disclose
Kenneth R. Hess
No relevant relationships to disclose
Sinchita Roy-Chowdhuri
No relevant relationships to disclose
Razelle Kurzrock
No relevant relationships to disclose
Funda Meric-Bernstam
No relevant relationships to disclose
David S. Hong
Research Funding - Amgen